Establishment and Methodological Evaluation of a Method for Rapid Detection of Helicobacter pylori and Virulence Genes Based on CRISPR-Cas12a
Yi Zhu,Chunhui Lin,Huaming Xu,Zhaoxin Xia,Wensu Yang,Hao Tang,Xinyi Hu,Tong Jiang,Zhen Liu,Jilu Shen
DOI: https://doi.org/10.2147/IDR.S398098
2023-01-25
Infection and Drug Resistance
Abstract:Yi Zhu, 1, 2 Chunhui Lin, 1, 2 Huaming Xu, 3 Zhaoxin Xia, 1, 2 Wensu Yang, 1, 2 Hao Tang, 4 Xinyi Hu, 1, 2 Tong Jiang, 1, 2 Zhen Liu, 1, 2 Jilu Shen 1, 2 1 The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 2 Anhui Public Health Clinical Center, Hefei, People's Republic of China; 3 The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, People's Republic of China; 4 The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China Correspondence: Jilu Shen, Tel +86 151 5515 2963, Email ; Introduction: More than half of the world's people are infected or have been infected with Helicobacter pylori . This infection is related to many diseases, with its pathogenicity related to virulence factors. Therefore, the rapid diagnosis of H. pylori and genotyping of virulence genes play an extremely important role in the clinical treatment and control of transmission. Methods: To this end, we developed a molecular detection method based on RPA- CRISPR-Cas12a technology for the specific genes 16S rDNA gene, cytotoxin associated gene A( cagA ), and vacuolating cytotoxin A ( vacA ) of H. pylori. Results: The results of which were displayed by lateral flow strips. Macroscopic observation takes only about 25 minutes and the sensitivity is 2ng/microliter. Discussion: The method is simple, convenient to operate and has low costs, and can therefore be applied widely to the detection and typing of H. pylori in various environments such as primary hospitals, community clinics, outdoors, and large medical institutions. Keywords: Helicobacter pylori , virulence genes, recombinase polymerase amplification, CRISPR-Cas12a, lateral flow immunochromatographic strip Helicobacter pylori (H. pylori ) is a Gram-negative, spiral microaerophilic bacterium that infects more than half of the world's population. 1,2 Studies have shown that this bacterium is the main pathogenic factor in chronic gastritis and peptic ulcers, and is related to the occurrence and development of gastric cancer. 3,4 For several decades, H. pylori is classified as a class I carcinogen by the International Agency for Research on Cancer (IARC). 5 The cytotoxin-associated gene A( cagA ) and vacuolating cytotoxin gene ( vacA ) of H. pylori are the main pathogenic factors. 6 Clinically, these strains are generally divided into type I or type II, with type I being positive for cagA and/or vacA and type II negative for both cagA and vacA in H. pylori serum antibody test. 7 Type II strains are almost non-toxic and generally cause only chronic superficial gastritis or no clinical symptoms after infection. Eradication may not be a blind option for people with type II and no clinical symptoms. Therefore, cagA and vacA virulence genotyping of H. pylori have become the key judgment indicators for clinical eradication treatment of patients with a H. pylori infection. At present, the commonly used detection methods for H. pylori include a 13 C or 14 C urea breath test (UBT), H. pylori fecal antigen test, and H. pylori serum antibody test. 8 However, these methods do not meet the needs of clinical detection and treatment due to several disadvantages such as radioactive contamination and inability to either genotyping the virulence of the strains or distinguish between previous and ongoing infections. In order to compensate for these shortcomings, we attempted to achieve rapid, accurate, and convenient detection method of H. pylori by combining recombinase polymerase amplification (RPA) with CRISPR-Cas12a technology. RPA is a novel isothermal acid amplification technique first proposed by Piepenburg et al in the UK in 2006. 9 This amplification can be completed under constant temperature conditions of 37–42 °C for 10–20 min and does not need a thermal cycle, water bath, or metal bath to meet the reaction conditions. This greatly reduces the cost, while the portable equipment can be deployed for field diagnosis, especially in areas with limited resources, making the method very suitable for instant detection. The CRISPR-Cas system is an adaptive immune system formed during the long-term evolution of prokaryotes. The system is distinguished from other systems by the complementary pairing of lead RNA -Abstract Truncated-